Lacosamide Injection
Product Images NDC 70710-1359

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70710-1359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0b3569ad 3273 4619 8cfe 144f48d99c40 01)

Chemical structure of lacosamide, showing the molecular arrangement including an acetyl group, amide bonds, and a phenyl ring, corresponding to the active ingredient in LACOSAMIDE injection 10 mg/mL by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Image (0b3569ad 3273 4619 8cfe 144f48d99c40 02)

A bar chart showing median percent change from baseline in seizure reduction across three studies comparing placebo to lacosamide at various mg/day doses. Each study compares placebo against one or more lacosamide doses, with lacosamide groups showing higher seizure reduction percentages ranging approximately from 26% to 40%.*

FDA Label Image

Image (0b3569ad 3273 4619 8cfe 144f48d99c40 03)

A line graph showing responder rate (equal to or greater improvement vs worsening) on the vertical axis and percent of patients on the horizontal axis, comparing placebo with lacosamide at 200 mg/day, 400 mg/day, and 600 mg/day doses. Four curves represent the different treatment groups, illustrating patient response distributions.*

FDA Label Image

Lacosamide Injection (0b3569ad 3273 4619 8cfe 144f48d99c40 04)

Label for Lacosamide Injection, USP 10 mg/mL (200 mg/20 mL) intravenous injection. The 20 mL single-dose vial is manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes dosage strength, route of administration, barcode, manufacturer and distributor information, storage instructions, and safety warnings.*

FDA Label Image

Lacosamide Injection (0b3569ad 3273 4619 8cfe 144f48d99c40 05)

Packaging label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection. The label indicates 10 single-dose vials of 20 mL each. Manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals USA Inc. Contains usage instructions, storage information, a barcode, and a caution note for pharmacists.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.